Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline

The Hallmarks of Aging

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

International Journal of Molecular Sciences

Soni, N., Ross, A., Nookaew, I., Scheers, N., Gabrielsson, B., & Sandberg, A.-S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms · Cited by 10,136 · see citing works

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

Hallmarks of aging: An expanding universe

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · see citing works

Lecanemab in early Alzheimer's disease

van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · see citing works

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · see citing works

Ageing as a risk factor for neurodegenerative disease

Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · see citing works

2023 Alzheimer's disease facts and figures

(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212 · see citing works

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · see citing works

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

Sims, J. R., Zimmer, J. A., Evans, C. D., Lu, M., Ardayfio, P., Sparks, J., Wessels, A. M., Shcherbinin, S., Wang, H., Monkul Nery, E. S., et al. (2023) · JAMA · doi:10.1001/jama.2023.13239 · Cited by 2,932 · see citing works

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment

Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789 · see citing works

mTOR at the nexus of nutrition, growth, ageing and disease

Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737 · see citing works

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595 · see citing works

The mechanisms of action of metformin

Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287 · see citing works

Inflammation as a central mechanism in Alzheimer's disease

Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253 · see citing works

Untitled work

Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194 · see citing works

The Amyloid-β Pathway in Alzheimer’s Disease

Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Alzheimer's Disease and the Amyloid-β Peptide

Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750 · see citing works

Donanemab in Early Alzheimer’s Disease

Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728 · see citing works

Hippocampal Volume Reduction in Major Depression

Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670 · see citing works

Role of neuroinflammation in neurodegeneration development

Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works

The role of apolipoprotein E in Alzheimer's disease

Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works

Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study

Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588 · see citing works

An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”

Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455 · see citing works

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425 · see citing works

Alzheimer’s Disease: The Challenge of the Second Century

Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · see citing works

Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease

Wilson, R. S. (2002) · JAMA · doi:10.1001/jama.287.6.742 · Cited by 1,312 · see citing works

Journal of the American Geriatrics Society

(1976) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1976.tb03307.x · Cited by 1,309 · see citing works

Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease

Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · see citing works

Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States

Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242 · see citing works

The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Pickford, F., Masliah, E., Britschgi, M., Lucin, K. M., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 1,186 · see citing works

Tau in Alzheimer Disease and Related Tauopathies

Iqbal, K., Liu, F., Gong, C., & Grundke, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,122 · see citing works

Tau-targeting therapies for Alzheimer disease

Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113 · see citing works

Classification and basic pathology of Alzheimer disease

Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031 · see citing works

Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future

Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988 · see citing works

Current and Future Treatments in Alzheimer Disease: An Update

Yiannopoulou, K. G., & Papageorgiou, S. G. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573520907397 · Cited by 966 · see citing works

The central role of DNA damage in the ageing process

Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907 · see citing works

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

Tapiola, T., Alafuzoff, I., Herukka, S.-K., Parkkinen, L., Hartikainen, P., Soininen, H., & Pirttilä, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.596 · Cited by 896 · see citing works

Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging

Ahlskog, J. E., Geda, Y. E., Graff-Radford, N. R., & Petersen, R. C. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0252 · Cited by 885 · see citing works

The genetic landscape of Alzheimer disease: clinical implications and perspectives

Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863 · see citing works

Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum

Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785 · see citing works

The Genetics of Alzheimer's Disease

Bertram, L., & Tanzi, R. E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 784 · see citing works

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756 · see citing works

Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis

Ciesielska, N., Sokołowski, R., Mazur, E., Podhorecka, M., Polak-Szabela, A., & Kędziora–Kornatowska, K. (2016) · Psychiatria Polska · doi:10.12740/pp/45368 · Cited by 739 · see citing works

A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study

Jia, X., Wang, Z., Huang, F., Su, C., Du, W., Jiang, H., Wang, H., Wang, J., Wang, F., Su, W., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03495-6 · Cited by 731 · see citing works

The genetics of Alzheimer disease

Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727 · see citing works

Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model

Price, R. B., & Duman, R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0615-x · Cited by 721 · see citing works

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases

Chin-Chan, M., Navarro-Yepes, J., & Quintanilla‐Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 712 · see citing works

Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness

Calcia, M., Bonsall, D. R., Bloomfield, P. S., Selvaraj, S., Barichello, T., & Howes, O. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4218-9 · Cited by 710 · see citing works

Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons

Rajmohan, R., & Reddy, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160612 · Cited by 695 · see citing works

Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition

Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650 · see citing works

Telomeres: history, health, and hallmarks of aging

Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637 · see citing works

Current Topics in Medicinal Chemistry

(2019) · Current Topics in Medicinal Chemistry · doi:10.2174/ctmc-15680266-615 · Cited by 629 · see citing works

Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications

Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., & Gibson, G. E. (2005) · Annals of Neurology · doi:10.1002/ana.20474 · Cited by 622 · see citing works

Risk factors for Alzheimer’s disease

Armstrong, R. A. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.85929 · Cited by 617 · see citing works

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases

Lanoiselée, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., Martinaud, O., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002270 · Cited by 616 · see citing works

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

Cummings, J. L., Tong, G., & Ballard, C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180766 · Cited by 588 · see citing works

Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk

Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562 · see citing works

Blood biomarkers for Alzheimer’s disease in clinical practice and trials

Hansson, O., Blennow, K., Zetterberg, H., & Dage, J. (2023) · Nature Aging · doi:10.1038/s43587-023-00403-3 · Cited by 522 · see citing works

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112841 · Cited by 509 · see citing works

New insights into the role of TREM2 in Alzheimer’s disease

Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489 · see citing works

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Maccioni, R. B., Muñoz, J. P., & Barbeito, L. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00316-2 · Cited by 474 · see citing works

Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

van Duijn, C. M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L., Hofman, A., & van Broeckhoven, C. (1994) · Nature Genetics · doi:10.1038/ng0594-74 · Cited by 472 · see citing works

Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests

Barthélemy, N. R., Salvadó, G., Schindler, S. E., He, Y., Janelidze, S., Collij, L. E., Saef, B., Henson, R. L., Chen, C. D., Gordon, B. A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02869-z · Cited by 448 · see citing works

The Role of Tau in Alzheimer's Disease and Related Disorders

Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 448 · see citing works

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441 · see citing works

Mitochondrial dysfunction in Alzheimer's disease: role in pathogenesis and novel therapeutic opportunities

Perez Ortiz, J. M., & Swerdlow, R. H. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14585 · Cited by 426 · see citing works

Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study

Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., Kiel, D. P., Lu, K. P., Seshadri, S., & Wolf, P. A. (2012) · BMJ · doi:10.1136/bmj.e1442 · Cited by 425 · see citing works

Physical activity as a protective factor for dementia and Alzheimer's disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies

Iso-Markku, P., Kujala, U. M., Knittle, K., Polet, J., Vuoksimaa, E., & Waller, K. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-104981 · Cited by 423 · see citing works

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care

Palmqvist, S., Tideman, P., Mattsson-Carlgren, N., Schindler, S. E., Smith, R., Ossenkoppele, R., Calling, S., West, T., Monane, M., Verghese, P. B., et al. (2024) · JAMA · doi:10.1001/jama.2024.13855 · Cited by 416 · see citing works

The age factor in Alzheimer’s disease

Guerreiro, R., & Bras, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0232-5 · Cited by 415 · see citing works

Telomeres and cell senescence—size matters not

Victorelli, S., & Passos, J. F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.027 · Cited by 413 · see citing works

Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases

Chi, H., Chang, H.-Y., & Sang, T.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103082 · Cited by 412 · see citing works

Age-Related Hearing LossPreprint

Bowl, M. R., & Dawson, S. J. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a033217 · Cited by 405 · see citing works

DNA damage-how and why we age?

Yousefzadeh, M., Henpita, C., Vyas, R., Soto-Palma, C., Robbins, P., & Niedernhofer, L. (2021) · eLife · doi:10.7554/elife.62852 · Cited by 399 · see citing works

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

Cummings, J. L., Osse, A. M. L., Cammann, D., Powell, J., & Chen, J. (2023) · BioDrugs · doi:10.1007/s40259-023-00633-2 · Cited by 396 · see citing works

Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression

Guo, B., Zhang, M., Hao, W., Wang, Y., Zhang, T., & Liu, C. (2023) · Translational Psychiatry · doi:10.1038/s41398-022-02297-y · Cited by 389 · see citing works

Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment

Initiative, A. D. N., Chandra, A., Dervenoulas, G., & Politis, M. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9016-3 · Cited by 386 · see citing works

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:

Grossberg, G. T. (2003) · Current Therapeutic Research · doi:10.1016/s0011-393x(03)00059-6 · Cited by 384 · see citing works

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies

Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381 · see citing works

Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives

Zhang, Z., Yang, X., Song, Y., & Tu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101464 · Cited by 378 · see citing works

APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

Fortea, J., Pegueroles, J., Alcolea, D., Belbin, O., Dols-Icardo, O., Vaqué-Alcázar, L., Videla, L., Gispert, J. D., Suárez-Calvet, M., Johnson, S. C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02931-w · Cited by 369 · see citing works

TDP-43 Pathology in Alzheimer’s Disease

Meneses, A. D., Koga, S., O’Leary, J., Dickson, D. W., Bu, G., & Zhao, N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00503-x · Cited by 360 · see citing works

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

Janelidze, S., Mattsson, N., Stomrud, E., Lindberg, O., Palmqvist, S., Zetterberg, H., Blennow, K., & Hansson, O. (2018) · Neurology · doi:10.1212/wnl.0000000000006082 · Cited by 359 · see citing works

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets

Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856376 · Cited by 351 · see citing works

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

Mummery, C. J., Börjesson-Hanson, A., Blackburn, D. J., Vijverberg, E. G. B., De Deyn, P. P., Ducharme, S., Jonsson, M., Schneider, A., Rinne, J. O., Ludolph, A. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02326-3 · Cited by 347 · see citing works

Stroke and the Risk of Alzheimer Disease

Honig, L. S., Tang, M., Albert, S. M., Costa, R., Luchsinger, J. A., Manly, J. J., Stern, Y., & Mayeux, R. P. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1707 · Cited by 344 · see citing works

Molecular Basis of Familial and Sporadic Alzheimer's Disease

Dorszewska, J., Prendecki, M., Oczkowska, A., Dezor, M., & Kozubski, W. P. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150501 · Cited by 329 · see citing works

The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology

Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324 · see citing works

Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures

Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321 · see citing works

Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease

Wang, M., Roussos, P., McKenzie, A., Zhou, X., Kajiwara, Y., Brennand, K. J., De Luca, G. C., Crary, J. F., Casaccia, P., Buxbaum, J. D., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0355-3 · Cited by 314 · see citing works

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease

Rodriguez, S., Hug, C., Todorov, P., Moret, N., Boswell, S. A., Evans, K., Zhou, G., Johnson, N. T., Hyman, B. T., Sorger, P. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21330-0 · Cited by 299 · see citing works

Cancer linked to Alzheimer disease but not vascular dementia

Roe, C. M., Fitzpatrick, A. L., Xiong, C., Sieh, W., Kuller, L. H., Miller, J. P., Williams, M. M., Kopan, R., Behrens, M. I., & Morris, J. C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c91873 · Cited by 288 · see citing works

Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease

Atamna, H., & Frey, W. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.06.001 · Cited by 278 · see citing works

Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review

Yegambaram, M., Manivannan, B., Beach, T. G., & Halden, R. U. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150204121719 · Cited by 277 · see citing works

Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement

Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00531 · Cited by 276 · see citing works

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 271 · see citing works

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

Patterson, C., Feightner, J., Garcia, A. C. S., Hsiung, G. R., MacKnight, C., & Sadovnick, A. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070796 · Cited by 266 · see citing works

Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease

Wingo, T. S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.221 · Cited by 265 · see citing works

The Impact of Disease Comorbidities in Alzheimer’s Disease

Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259 · see citing works

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Lee, J. C., Kim, S. J., Hong, S., & Kim, Y. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0250-2 · Cited by 253 · see citing works

Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?

Jeon, S. W., & Kim, Y. K. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i3.283 · Cited by 247 · see citing works

Role of structural MRI in Alzheimer's disease

Vemuri, P., & Jack, C. R. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt47 · Cited by 246 · see citing works

Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome

Hernández‐Ortega, K., Garcia‐Esparcia, P., Gil, L., Lucas, J. J., & Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12335 · Cited by 245 · see citing works

Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease

TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242 · see citing works

Epigenetics of Aging and Aging-Associated Diseases

Saul, D., & Kosinsky, R. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010401 · Cited by 241 · see citing works

Synaptic plasticity and mental health: methods, challenges and opportunities

Appelbaum, L. G., Shenasa, M. A., Stolz, L., & Daskalakis, Z. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01370-w · Cited by 240 · see citing works

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Ardura-Fabregat, A., Boddeke, E., Boza‐Serrano, A., Brioschi, S., Castro‐Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 236 · see citing works

The role of oxidative stress in anxiety disorder: cause or consequence?

Fedoce, A. G., Ferreira, F. R., Bota, R. G., Bonet-Costa, V., Sun, P. Y., & Davies, K. J. A. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1475733 · Cited by 235 · see citing works

Chronic Stress and Oxidative Stress as Common Factors of the Pathogenesis of Depression and Alzheimer’s Disease: The Role of Antioxidants in Prevention and Treatment

Juszczyk, G., Mikulska, J., Kasperek, K., Pietrzak, D., Mrozek, W., & Herbet, M. (2021) · Antioxidants · doi:10.3390/antiox10091439 · Cited by 235 · see citing works

Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

Botto, R., Callai, N., Cermelli, A., Causarano, L., & Rainero, I. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06068-x · Cited by 233 · see citing works

Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays

Ashton, N. J., Puig‐Pijoan, A., Milà‐Alomà, M., Fernández‐Lebrero, A., García‐Escobar, G., González‐Ortiz, F., Kac, P. R., Brum, W. S., Benedet, A. L., Lantero‐Rodriguez, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12841 · Cited by 230 · see citing works

Meta-analysis of Telomere Length in Alzheimer’s Disease

Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw053 · Cited by 229 · see citing works

Quantification of amyloid PET for future clinical use: a state-of-the-art review

Pemberton, H. G., Collij, L. E., Heeman, F., Bollack, A., Shekari, M., Salvadó, G., Alves, I. L., Garcia, D. V., Battle, M., Buckley, C., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05784-y · Cited by 226 · see citing works

The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation

Moudgil, K. D., & Venkatesha, S. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010095 · Cited by 221 · see citing works

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220 · see citing works

Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment

Lombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009628.pub2 · Cited by 214 · see citing works

NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer’s models

Bahn, G., Park, J.-S., Yun, U. J., Lee, Y. J., Choi, Y., Park, J. S., Baek, S. H., Choi, B. Y., Cho, Y. S., Kim, H. K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819541116 · Cited by 210 · see citing works

Hypomethylation of the amyloid precursor protein gene in the brain of an alzheimer’s disease patient

West, R. L., Lee, J. M., & Maroun, L. E. (1995) · Journal of Molecular Neuroscience · doi:10.1007/bf02736773 · Cited by 208 · see citing works

Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy

Picone, P., Nuzzo, D., Caruana, L., Scafidi, V., & Carlo, M. D. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/780179 · Cited by 208 · see citing works

Mitochondrial Dysfunction in Alzheimers Disease: Opportunities forDrug Development

Bhatia, S., Rawal, R., Sharma, P., Singh, T., Singh, M., & Singh, V. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210517114016 · Cited by 197 · see citing works

Telomere biology and age-related diseases

Herrmann, M., Pusceddu, I., März, W., & Herrmann, W. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0870 · Cited by 193 · see citing works

Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects

Lee, H. J., Seo, H. I., Yun, H. S., Yang, Y. J., Kwon, S. H., & Yang, S. J. (2018) · Clinical Nutrition Research · doi:10.7762/cnr.2018.7.4.229 · Cited by 190 · see citing works

Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders

Won, E., & Kim, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186546 · Cited by 184 · see citing works

New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage

Petit-Paitel, A., Bihel, F. J. ‐., da Costa, C. A., Pourquié, O., Checler, F., & Kraus, J. (2001) · Nature Cell Biology · doi:10.1038/35074581 · Cited by 178 · see citing works

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Gramont, A. D. E., Watson, S., Ellis, L. M., Rodon, J. A., Tabernero, J. M., de Gramont, A., & Hamilton, S. R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.202 · Cited by 174 · see citing works

Late-onset vs nonmendelian early-onset Alzheimer disease

Reitz, C., Rogaeva, E. A., & Beecham, G. W. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000512 · Cited by 171 · see citing works

Late-onset Alzheimer Disease

Rabinovici, G. D. (2019) · Continuum · doi:10.1212/con.0000000000000700 · Cited by 170 · see citing works

Amyloid-β-Induced Mitochondrial Dysfunction

Chen, J. X., & Yan, S. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12208 · Cited by 167 · see citing works

Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

Yamazaki, Y., Painter, M. M., Bu, G., & Kanekiyo, T. (2016) · CNS Drugs · doi:10.1007/s40263-016-0361-4 · Cited by 166 · see citing works

Apolipoprotein E and Alzheimer's disease

Troutwine, B., Hamid, L., Lysaker, C. R., Strope, T. A., & Wilkins, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.002 · Cited by 164 · see citing works

Depression and the hippocampus: cause or effect?

Sheline, Y. I. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.006 · Cited by 159 · see citing works

Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

SWATTON, J. E., Sellers, L. A., Faull, R. L. M., Holland, A. J., Iritani, S., & Bahn, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03365.x · Cited by 158 · see citing works

Telomere shortening in neurological disorders: an abundance of unanswered questions

Eitan, E., Hutchison, E. R., & Mattson, M. P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.010 · Cited by 158 · see citing works

Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing

Rossiello, F., Herbig, U., Longhese, M. P., Fumagalli, M., & di Fagagna, F. D. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.06.009 · Cited by 156 · see citing works

DNA Damage and Repair in Alzheimers Disease

Coppede, F., & Migliore, L. (2009) · Current Alzheimer Research · doi:10.2174/156720509787313970 · Cited by 148 · see citing works

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Giacomucci, G., Mazzeo, S., Bagnoli, S., Ingannato, A., Leccese, D., Berti, V., Padiglioni, S., Galdo, G., Ferrari, C., Sorbi, S., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11055-5 · Cited by 148 · see citing works

Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage

Reddy, P. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.012 · Cited by 147 · see citing works

Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch

Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M. G., Baumeister, R., & Haass, C. (2000) · Nature Cell Biology · doi:10.1038/35008626 · Cited by 147 · see citing works

Plasma Amyloid-β (Aβ 42 ) Correlates with Cerebrospinal Fluid Aβ 42 in Alzheimer’s Disease

Teunissen, C. E., Chiu, M., Yang, C., Yang, S., Scheltens, P., Zetterberg, H., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170784 · Cited by 146 · see citing works

Bridging Integrator 1 (BIN1) Protein Expression Increases in the Alzheimer's Disease Brain and Correlates with Neurofibrillary Tangle Pathology

Holler, C. J., Davis, P. R., Beckett, T. L., Platt, T. L., Webb, R. L., Head, E., & Murphy, M. P. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132450 · Cited by 145 · see citing works

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials

Wu, W., Ji, Y., Wang, Z., Wu, X., Li, J., Gu, F., Chen, Z., & Wang, Z. (2023) · European journal of medical research · doi:10.1186/s40001-023-01512-w · Cited by 145 · see citing works

Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and Apoptosis in Alzheimer’s Disease

Takuma, K., Yan, S. S., Stern, D. M., & Yamada, K. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cpj04006x · Cited by 143 · see citing works

In vitro prion-like behaviour of TDP-43 in ALS

Smethurst, P., Newcombe, J., Troakes, C., Simone, R., Chen, Y., Patani, R., & Sidle, K. C. L. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.007 · Cited by 139 · see citing works

Loss‐of‐function mutation in <i>ABCA1</i> and risk of Alzheimer's disease and cerebrovascular disease

Nordestgaard, L. T., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2015.04.006 · Cited by 139 · see citing works

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Giau, V. V., Bagyinszky, E., Yang, Y. S., Youn, Y. C., An, S. S. A., & Kim, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-44848-2 · Cited by 133 · see citing works

Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease

Wu, Y., Li, Z., Huang, Y., Wu, D., & Luo, H. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01370 · Cited by 129 · see citing works

Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI

Wolters, F. J., Zonneveld, H. I., Licher, S., Cremers, L. G. M., Ikram, M. A., Koudstaal, P. J., Vernooij, M. W., & Ikram, M. A. (2019) · Neurology · doi:10.1212/wnl.0000000000008003 · Cited by 129 · see citing works

Treatment Strategies Targeting Amyloid -ProteinPreprint

Schenk, D., Basi, G. S., & Pangalos, M. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006387 · Cited by 128 · see citing works

TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease

Li, Y., Xu, H., Wang, H., Yang, K., Luan, J., & Wang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115218 · Cited by 128 · see citing works

Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force

Angioni, D., Delrieu, J., Hansson, O., Fillit, H. M., Aisen, P. S. S., Cummings, J. L., Sims, J. R., Braunstein, J. B., Sabbagh, M. N., Bittner, T., et al. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.85 · Cited by 125 · see citing works

Genome instability in Alzheimer disease

Hou, Y., Song, H., Croteau, D. L., Akbari, M., & Bohr, V. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.005 · Cited by 120 · see citing works

Robust amyloid clearance in a mouse model of Alzheimer’s disease provides novel insights into the mechanism of amyloid-β immunotherapy

Wang, A., Das, P., Switzer, R. C., Golde, T. E., & Jankowsky, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5077-10.2011 · Cited by 118 · see citing works

Contributions of DNA Damage to Alzheimer’s Disease

Lin, X., Kapoor, A., Gu, Y., Chow, M. J., Peng, J., Zhao, K., & Tang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051666 · Cited by 117 · see citing works

Association between chronic stress and Alzheimer’s disease: Therapeutic effects of Saffron

Saeedi, M., & Rashidy‐Pour, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110995 · Cited by 117 · see citing works

The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease

Jung, Y., & Damoiseaux, J. S. (2023) · Brain · doi:10.1093/brain/awad267 · Cited by 117 · see citing works

Conversion between the Montreal Cognitive Assessment and the Mini‐Mental Status Examination

Fasnacht, J. S., Wueest, A. S., Berres, M., Thomann, A. E., Krumm, S., Gutbrod, K., Steiner, L. A., Goettel, N., & Monsch, A. U. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18124 · Cited by 117 · see citing works

Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications

Tang, B., Wang, Y., & Ren, J. (2023) · Ibrain · doi:10.1002/ibra.12098 · Cited by 114 · see citing works

Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease

Heckmann, B. L., Teubner, B. J. W., Boada-Romero, E., Tummers, B., Guy, C., Fitzgerald, P., Mayer, U., Carding, S., Zakharenko, S. S., Wileman, T., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb9036 · Cited by 114 · see citing works

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Gilbert, M. A. G., Fatima, N., Jenkins, J., O’Sullivan, T. J., Schertel, A., Halfon, Y., Wilkinson, M., Morrema, T. H. J., Geibel, M., Read, R. J., et al. (2024) · Nature · doi:10.1038/s41586-024-07680-x · Cited by 112 · see citing works

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease

Jie, C. V. M. L., Treyer, V., Schibli, R., & Mu, L. (2021) · Pharmaceuticals · doi:10.3390/ph14020110 · Cited by 111 · see citing works

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois, B., López‐Arrieta, J., Lipschitz, S., Doskas, T. K., Spiru, L., Moroz, S., Venger, O., Vermersch, P., Moussy, A., Mansfield, C. D., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01169-x · Cited by 110 · see citing works

The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer’s Disease

Hillen, H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01154 · Cited by 106 · see citing works

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders

An, S. S. A., Cai, Y., & Kim, S. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s85808 · Cited by 105 · see citing works

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research

Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102 · see citing works

Conn's Handbook of Models for Human Aging

(2018) · Elsevier eBooks · doi:10.1016/c2016-0-00505-3 · Cited by 102 · see citing works

Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis

Weidling, I. W., & Swerdlow, R. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113321 · Cited by 100 · see citing works

Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease

Matthews, D. C., Mao, X., Dowd, K., Tsakanikas, D., Jiang, C. S., Meuser, C., Andrews, R. D., Lukic, A. S., Lee, J., Hampilos, N. H., et al. (2021) · Brain · doi:10.1093/brain/awab222 · Cited by 99 · see citing works

Autophagy protein NRBF2 has reduced expression in Alzheimer’s brains and modulates memory and amyloid-beta homeostasis in mice

Lachance, V., Wang, Q., Sweet, E., Choi, I., Cai, C.-Z., Zhuang, X.-X., Zhang, Y., Jiang, J. L., Blitzer, R. D., Bozdagi-Gunal, O., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0342-4 · Cited by 96 · see citing works

Functional Genomics of Brain Aging and Alzheimers Disease: Focus on Selective Neuronal Vulnerability

Wang, X., Michaelis, M. L., & Michaelis, E. K. (2010) · Current Genomics · doi:10.2174/138920210793360943 · Cited by 93 · see citing works

Stress, depression, and risk of dementia – a cohort study in the total population between 18 and 65 years old in Region Stockholm

Wallensten, J. C., Ljunggren, G., Nager, A., Wachtler, C., Bogdanović, N., Petrović, P., & Carlsson, A. C. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01308-4 · Cited by 93 · see citing works

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease

Liu, P., Wang, Y., Sun, Y., & Peng, G. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s357558 · Cited by 92 · see citing works

Clinical and Translational Science

(2010) · Clinical and Translational Science · doi:10.1111/(issn)1752-8062 · Cited by 91 · see citing works

International Work Group Criteria for the Diagnosis of Alzheimer Disease

Cummings, J. L., Dubois, B., Molinuevo, J. L., & Scheltens, P. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.01.001 · Cited by 88 · see citing works

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Visser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martínez‐Lage, P., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00521-3 · Cited by 88 · see citing works

The Patterns of Inheritance in Early-Onset Dementia

Jarmolowicz, A. I., Chen, H.-Y., & Panegyres, P. K. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514545825 · Cited by 87 · see citing works

Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects

Loeffler, D. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230025 · Cited by 86 · see citing works

Selective serotonin reuptake inhibitors and Alzheimer’s disease

Khoury, R., Mdawar, B., & Ghossoub, E. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.264445 · Cited by 84 · see citing works

Dynamic Regulation of Cerebral Blood Flow in Patients With Alzheimer Disease

de Heus, R. A. A., de Jong, D. L. K., Sanders, M. L., van Spijker, G. J., Oudegeest‐Sander, M. H., Hopman, M. T. E., LAWLOR, B. A., Rikkert, M. G. M. O., & Claassen, J. A. H. R. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10900 · Cited by 82 · see citing works

Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents

Pasieka, A., Panek, D., Szałaj, N., Espargaró, A., Więckowska, A., Malawska, B., Sabaté, R., & Bajda, M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00235 · Cited by 82 · see citing works

Sex hormones, obesity and type 2 diabetes: is there a link?

Gambineri, A., & Pelusi, C. (2018) · Endocrine Connections · doi:10.1530/ec-18-0450 · Cited by 82 · see citing works

Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD

Hayes, L. R., & Kaláb, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01260-5 · Cited by 81 · see citing works

Impairment of PGC-1α-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease

Singulani, M. P., Pereira, C. P. M., Ferreira, A. F. F., Garcia, P. C., Ferrari, G. D., Alberici, L. C., & Britto, L. R. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110882 · Cited by 80 · see citing works

Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer’s disease

Patel, V., & Edison, P. (2024) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2023-332661 · Cited by 80 · see citing works

Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease

Ricciarelli, R., Brullo, C., Prickaerts, J., Arancio, O., Villa, C., Rebosio, C., Calcagno, E., Balbi, M., van Hagen, B. T. J., Argyrousi, E. K., et al. (2017) · Scientific Reports · doi:10.1038/srep46320 · Cited by 78 · see citing works

Repurposed agents in the Alzheimer’s disease drug development pipeline

Bauzon, J., Lee, G., & Cummings, J. (2020) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-020-00662-x · Cited by 77 · see citing works

Vision Loss in Older Adults.

Pelletier, A. L., Rojas-Roldan, L., & Coffin, J. S. (2016) · PubMed · Cited by 73 · see citing works

Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview

Zabłocka, A., Kazana, W., Sochocka, M., Stańczykiewicz, B., Janusz, M., Leszek, J., & Orzechowska, B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02544-1 · Cited by 73 · see citing works

Neurology and Clinical Neuroscience

(2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03354-1.x5001-9 · Cited by 73 · see citing works

Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation

Yan, C., Grabowska, M. E., Dickson, A. L., Li, B., Wen, Z., Roden, D. M., Michael Stein, C., Embí, P. J., Peterson, J. F., Feng, Q., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01038-3 · Cited by 73 · see citing works

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 72 · see citing works

Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors

Takeda, S. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.08.005 · Cited by 71 · see citing works

Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer’s disease

Schultz, S. A., Larson, J., Oh, J. M., Koscik, R. L., Dowling, N. M., Gallagher, C. L., Carlsson, C. M., Rowley, H. A., Bendlin, B. B., Asthana, S., et al. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-014-9329-5 · Cited by 70 · see citing works

Anti-Amyloid Monoclonal Antibodies for Alzheimer’s Disease: Evidence, ARIA Risk, and Precision Patient Selection

Alkhalifa, A. E., Mokhlf, A. A., Ali, H., Al-Ghraiybah, N. F., & Syropoulou, V. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15090437 · Cited by 62 · see citing works

Hybrid Deep Learning Architecture with Adaptive Feature Fusion for Multi-Stage Alzheimer’s Disease Classification

Muhammad, A., Qi, J., Elwasila, O., & Gulzar, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15060612 · Cited by 27 · see citing works

Potential common pathogenesis of several neurodegenerative diseases

Fan, T., Peng, J., Liang, H., Chen, W., Wang, J., & Xu, R. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01054 · Cited by 29 · see citing works

A Novel Diagnostic Framework with an Optimized Ensemble of Vision Transformers and Convolutional Neural Networks for Enhanced Alzheimer’s Disease Detection in Medical Imaging

Bortty, J. C., Chakraborty, G. S., Noman, I. R., Batra, S., Das, J., Bishnu, K. K., Tarafder, M. T. R., & Islam, A. (2025) · Diagnostics · doi:10.3390/diagnostics15060789 · Cited by 21 · see citing works

Unraveling the Complexity of Alzheimer’s Disease: Insights into Etiology and Advancements in Treatment Strategies

Khan, B., Iqbal, M. K., Khan, M. A., Khan, H. R., Kiyani, M. M., Bashir, S., & Li, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02337-4 · Cited by 17 · see citing works

The potential of plant-derived vesicles in treating periodontitis and associated systemic diseases: current advances and future directions

Liu, Z., Guo, Y., Deng, Y., Shao, J., Huang, X., & Cao, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03651-0 · Cited by 16 · see citing works

Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosis

Bhujbal, S. P., & Hah, J. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01566-w · Cited by 16 · see citing works

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Coumarin–Triazole–Isatin Hybrids as Selective Butyrylcholinesterase Inhibitors

Dimkovski, A., Dobričić, V., Simić, M. R., Pavlova, M. J., Mihajloska, E., Sterjev, Z., & Panovska, A. P. (2025) · Molecules · doi:10.3390/molecules30102121 · Cited by 15 · see citing works

Protection of Green Tea Polyphenols against Neurodegenerative Diseases: Evidence and Possible Mechanisms

Zhao, B., & Zhao, B. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.02.010 · Cited by 15 · see citing works

Metal nanocomposites for biosensing amyloid beta peptides: Advancing point-of-care diagnostics in Alzheimer's disease

Natarajan, B., Zhou, Q., Maduraiveeran, G., & Kannan, P. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217682 · Cited by 12 · see citing works

Mechanisms and Impact of Cognitive Reserve in Normal Aging and Alzheimer’s Disease

Simfukwe, C., An, S. S. A., & Youn, Y. C. (2025) · Diagnostics · doi:10.3390/diagnostics15233068 · Cited by 9 · see citing works

Moderate drinking benefits cognitive health in middle-aged and older Chinese: A latent class growth model analysis based on CHARLS

Xie, Z., Zhang, Z., Bi, K., Huang, S., Zhao, M., & Du, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.134 · Cited by 8 · see citing works

Design, synthesis, and biological evaluation of caffeic acid-based novel multifunctional molecules for the management of Alzheimer's disease

kumar, S., V, & Modi, G. P. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117831 · Cited by 10 · see citing works

Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation

Yadav, A. K., Verma, P., Srivastava, A., Srivastava, P., Rai, R., & Rathour, S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02113-9 · Cited by 7 · see citing works

Sleep‐Dependent Clearance of Brain Metabolites via the Glymphatic System: Implications for Alzheimer's Pathophysiology

Zare, F., Shakhmurova, G., Rizaev, J., Smerat, A., Abbood, R. S., Patil, V., & Kumar‐Mishra, M. (2026) · Brain and Behavior · doi:10.1002/brb3.71374 · Cited by 7 · see citing works

Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer’s disease and Parkinson’s disease

Liu, Y., Zhang, J., Tang, L., Yang, J., Hao, L., Lou, F., & Su, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04174-1 · Cited by 8 · see citing works

Nanobody Therapeutics in Alzheimer’s Disease: From Molecular Mechanisms to Translational Approaches

Godugu, D., Gattu, K., Suri, P., Daartey, A. B., Jadhav, K., & Rojekar, S. V. (2025) · Antibodies · doi:10.3390/antib15010001 · Cited by 6 · see citing works

Recent advances in polymeric nanoparticle-mediated drug delivery system across the blood-brain barrier in Alzheimer’s disease

Rajkumar, M., Kirubakaran, D., Govindaraj, P., Shanmugarathinam, A., Deepak, P., Rajkumar, P., Uvarajan, D., Uddandrao, V. V. S., Rajendran, M., & Balamurugan, P. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115612 · Cited by 6 · see citing works

A timeline of structural and functional consequences to ipRGCs in a mouse model of Alzheimer’s disease

Recio, B. S., Pérez, W. A., Tjondropurnomo, R., Hsu, J., Ahmed, S., Parikh, S., Sun, J., Mitra, S., Goit, R. K., Brecha, N. C., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.12.007 · Cited by 5 · see citing works

Overcoming the blood–brain barrier in Alzheimer's disease: translational perspectives on advanced drug delivery platforms

Roamcharern, N., & Yubolphan, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810486 · Cited by 4 · see citing works

Neuroprotection through adiponectin receptor agonist: an updated meta-analysis of preclinical Alzheimer’s disease studies

Novinbahador, T., Abbasi, A., Molani‐Gol, R., Maleki, L. A., Pouraghaei, A., & Soleimanpour, H. (2025) · BMC Neurology · doi:10.1186/s12883-025-04356-5 · Cited by 4 · see citing works

Recent Advances and Future Directions in Alzheimer’s Disease Genetic Research

Stancheva, M., Toncheva, D. I., & Karachanak-Yankova, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167819 · Cited by 4 · see citing works

Upconversion nanoparticle-FITC conjugate as a fluorescence switching probe for the sensitive detection of Tau: an Alzheimer’s disease biomarker

Abraham, M. K., Indongo, G., Rajeevan, G., Arathy, B. K., Dhahir, D. M., & George, S. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07464-8 · Cited by 4 · see citing works

Genetic and epigenetic drivers of neurodegenerative disorders

Roy, K., Syed, M., Narad, P., & Sengupta, A. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.002 · Cited by 5 · see citing works

Conserved Blood Transcriptome Patterns Highlight microRNA and Hub Gene Drivers of Neurodegeneration

Cerna, J. L. O. D. L., Talubo, N. D. D., Villanueva, B. H. A., Tsai, P., & Tayo, L. L. (2025) · Genes · doi:10.3390/genes16101178 · Cited by 4 · see citing works

Advances in neurological therapies: A review of clinical trials in Alzheimer’s, Parkinson’s, and multiple sclerosis

de Souza, P. C., Bezerra, T. P. W., Rêgo, M. J. B. D. M., & da Rosa, M. M. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.11.025 · Cited by 4 · see citing works

Therapeutic and Diagnostic Roles of MSC‐Derived Exosomes in Alzheimer's Disease

Patil, V. S., Parekh, B. K., Sharma, A., Farah, H., Renuka Jyothi, S., Mishra, S. S., Nanda, A., Al-Hasnaawei, S., & Kumar‐Mishra, M. (2025) · Brain and Behavior · doi:10.1002/brb3.71112 · Cited by 5 · see citing works

Mapping the Ischemic Continuum: Dynamic Multi-Omic Biomarker and AI for Personalized Stroke Care

Grigorean, V. T., Panţu, C., Breazu, A., Oprea, S., Munteanu, O., Rădoi, M. P., Giuglea, C., & Marin, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010502 · Cited by 6 · see citing works

Design, synthesis and biological evaluation of donepezil-safinamide hybrids as dual AChE and MAO-B inhibitor for Alzheimer’s disease treatment

Li, W., Guo, Y., Wang, X., Yang, C., Zhu, J., & Cao, Z. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2026.2622769 · Cited by 4 · see citing works

Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration

Mózes, N., Varga, J. T., Szwajgier, D., Kryczyk‐Poprawa, A., Zábó, V., Lehoczki, A., Lipécz, Á., Csípő, T., Fazekas‐Pongor, V., Major, D., et al. (2026) · Nutrients · doi:10.3390/nu18091470 · Cited by 4 · see citing works

Oral Health in Alzheimer's Disease: A Life‐Course Perspective on Clinical Management and Caregiver Support

Silva, M. G., Vasconcelos, M. B., Silva, R. G., & Feitosa, M. Á. L. (2026) · Special Care in Dentistry · doi:10.1111/scd.70179 · Cited by 4 · see citing works

Molecular Mechanisms Underlying Alzheimer’s Disease Pathogenesis: Comprehensive Overview

Vecchio, F. L., la Torre, A., Gravina, C., D’Onofrio, G., & Greco, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104651 · Cited by 4 · see citing works

Design, Synthesis, and Biological Evaluation of Benzimidazol‐2‐One Hybrids as Potential Anti‐Alzheimer's Disease Agents

Yılmaz, F., Menteşe, E., Eyüpoğlu, O. E., Kahveci, B., & Emirik, M. (2026) · Drug Development Research · doi:10.1002/ddr.70369 · Cited by 4 · see citing works

Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer’s disease

Çam, S. A., Uysal, F., Doğan, H. T., Parlar, A., Çetinkaya, A., & Arslan, S. O. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149918 · Cited by 3 · see citing works

Exploring Thiophene-Based Pharmacophores as Emerging Therapeutics for Neurodegenerative Disorders

Sharma, S., Gupta, M., & Sharma, S. (2025) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2025.2554239 · Cited by 3 · see citing works

Exploring the molecular mechanisms of Pueraria in Alzheimer’s disease treatment using machine learning and network pharmacology

Ye, K., Li, L., Guan, L., Qin, M.-M., Xu, X., Wu, J., Huang, L.-Z., & Gao, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1683852 · Cited by 3 · see citing works

Therapeutic potential of third molar-derived dental pulp stem cells in Alzheimer’s disease: Current evidence and future directions

Wagaskar, P., Suryawanshi, M. V., Patil, A., & Pardeshi, V. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102949 · Cited by 3 · see citing works

Silencing SOX2-OT alleviates A β -induced damage to neurons and microglial cells by targeting miR-143-3p in Alzheimer’s disease

Huang, T., Wang, X., & Liu, Y. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf159 · Cited by 3 · see citing works

The eye–mind connection: a systematic review of retinal biomarkers and ocular signatures in major psychiatric disorders

Motamedi, R., Mehrizi, F. H., Abadi, M. Z. A., Mohagheghi, M., Fomeshi, F. N., Mousavikhah, S. E., Ghaffarzadeh, A., Yaghmayee, S., Bafrani, M. A., Rafiei, S. K. S., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-03664-3 · Cited by 3 · see citing works

Gentisic acid confers multimodal neuroprotection in experimental Alzheimer’s disease by targeting oxidative stress, neuroinflammation, and protein aggregation

Soni, U., & Pujari, R. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158276 · Cited by 3 · see citing works

From Molecular Networks to Medicines: Targeting Complexity in Alzheimer’s Disease (AD) Therapy

Kumar, D. R. P., Patel, S., Mishra, P. S., Srivastava, S., Sridhar, S. B., Shareef, J., Sahu, R., Tariq, M., Uddin, J., & Muhsinah, A. B. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05909-6 · Cited by 3 · see citing works

A Age Related Vascular Senescence: Mystery of Blood-brain Barrier Dysfunction in Neurodegeneration

Behl, T., Jayabalan, K., Ballal, S., Sahoo, S., Chellammal, H. S. J., Gulati, M., Anand, K., Jha, S. K., & Gasmi, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05984-9 · Cited by 3 · see citing works

Novel aptamers targeting heparan sulfate for delivery of RNA therapeutics in Alzheimer’s disease

Mehmood, A., Shah, A. Z., Juarez, J. A. M., Liu, X., Jiang, H., & Wang, X. (2026) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ae7eb9 · Cited by 3 · see citing works

Development of novel diaryl ether–phenolic Mannich Base derivatives with potent cholinesterase inhibition and low neuronal toxicity

Şenol, H., Demir, Y., Tokalı, P., Şenol, A. M., Akyıldırım, O., & Tokalı, F. S. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110354 · Cited by 3 · see citing works

Nonequilibrium landscape of amyloid-beta and calcium ions in application to Alzheimer's disease

Pal, S., & Melnik, R. (2025) · Physical review. E · doi:10.1103/physreve.111.014418 · Cited by 3 · see citing works

The Vicious Consequences of Chronic Kidney Disease on Cognitive Impairment and Alzheimer’s Disease

Roy, A., Roy, R., Bhattacharya, P., & Borah, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00050 · Cited by 6 · see citing works

HEXIM1/P–TEFb complex controls RNA polymerase II pause release and immediate early gene induction following neuronal depolarization

Htet, M., Estay-Olmos, C., Hu, L., Wu, Y., Powers, B. E., Campbell, C. D., Rameshwar, A., Ahmed, M. R., Hohman, T. J., Wang, Y., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111325 · Cited by 4 · see citing works

Thymoquinone regulates RSL3-induced ferroptosis in the alzheimer mouse hippocampus

Yılmaz, Ş. G., Almallohy, A. M., Deveci, H. A., Korkmaz, M., & Balcı, S. O. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11053-6 · Cited by 2 · see citing works

Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer’s disease

Hossen, F., Hung, J., Odeh, H., Sun, G. Y., & Lee, J. C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1671986 · Cited by 2 · see citing works

Anti-neuroinflammatory polyprenylated acylphloroglucinols from Hypericum patulum: LC-MS/MS-guided isolation, semi-synthesis, and TLR4 inhibition

Zhang, F., Chen, L., Jin, J., Ma, H., Li, Y., Xiao, T., Zeng, Y., Yang, J., Hao, X., & Yuan, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109292 · Cited by 2 · see citing works

Interpretable machine learning models for predicting cognitive impairment using NHANES neuropsychological tests: nutritional and sociodemographic associations

Song, L., Li, C., Xiang, X., & Lin, P. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1680290 · Cited by 2 · see citing works

The anti-Alzheimer potential of new spirooxindole derivatives containing 1,4-dihydropyridines as a targeted cholinesterase inhibitor

Pourtaher, H., Mohammadizadeh, M. R., Aliabadi, A., & Iraji, A. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103067 · Cited by 2 · see citing works

Novel cinnamic acid-based N -benzyl pyridinium analogs: potent dual cholinesterase inhibitors with neuroprotective properties for Alzheimer's disease

Esmkhani, M., Mahdavi, M. R., Javanshir, S., & Iraji, A. (2026) · RSC Advances · doi:10.1039/d5ra06941f · Cited by 2 · see citing works

Lower Plasma Serotonin is Associated with Higher Amyloid Burden, Hippocampal Atrophy, and Cognitive decline in Alzheimer’s Disease: A 24-Month Longitudinal Study

Han, Y., Liu, L., Li, C., Ge, X., Chen, Q., Li, Q., Li, H., Li, W., & Initiative, A. D. N. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02497-x · Cited by 2 · see citing works

The neuroprotective effects of Ocimum gratissimum-supplemented diet on scopolamine-induced memory impairment in mice model of Alzheimer’s Disease

Akanbi, D. A., OGBORIGA, P. O., Adeniyi, I. A., Lawal, A. O., Olusola, M. A., OLUYEMI, P. A., & Onasanwo, S. A. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.100979 · Cited by 2 · see citing works

Curcumin and Glycyrrhiza glabra Synergistically Attenuate Alzheimer’s Pathology via TLR4/NF-κB-Mediated Anti-inflammatory and Redox Modulation in a d-Gal/Sodium Nitrite-Induced Mouse Model

Liu, S., Yan, J., & Dong, J. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04746-2 · Cited by 2 · see citing works

From Laboratory to Patient Access: A Scoping Review of the Multi-Dimensional Challenges in Drug Repurposing

Ivanov, A., Ruseva, V., Hababa-Ivanova, I., Getova-Kolarova, V., Lebanova, H. V., & Getov, I. N. (2026) · Pharmacy · doi:10.3390/pharmacy14030085 · Cited by 2 · see citing works

Harmonizing the oral-brain axis: Music-induced microbiota shifts in age-related cognitive disorders and healthy agingPreprint

Castelo-Martínez, L., Mallah, N. E. Z., Cavenaghi, A., Navarro, L., Martinón‐Torres, F., Gómez‐Carballa, A., & Salas, A. (2025) · medRxiv · doi:10.1101/2025.07.29.25332408 · Cited by 2 · see citing works

Examining pharmacological and demographic factors among male and female alzheimer’s disease patients diagnosed with attention concentration disorder and cognitive communication disorder

Desai, A., Agbomi, L. L., Imeh‐Nathaniel, A., Nathaniel, E. I., Roley, L. T., Goodwin, R. L., & Nathaniel, T. I. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103769 · Cited by 1 · see citing works

Dimethylglycine as a Potent Modulator of Catalase Stability and Activity in Alzheimer’s Disease

Adhikarimayum, P., Yumlembam, S., Singh, K., Gupta, A., Sarangthem, K., & Singh, L. R. (2025) · Biophysica · doi:10.3390/biophysica6010002 · Cited by 1 · see citing works

Professionals’ prerequisites and preparedness for supporting young people living with a parent with dementia

Hedman, R., Tyrrell, M., Jönsson, A., Södergren, U., Sandberg, J., & Craftman, Å. G. (2026) · European Journal of Social Work · doi:10.1080/13691457.2025.2599088 · Cited by 1 · see citing works

Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease

Khan, S. A., Raza, K., Tiwari, P., El‐Tanani, M., Rabbani, S. A., & Parvez, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1676065 · Cited by 1 · see citing works

An Automated Image-Based Classification of Alzheimer’s Disease via CNN Transfer Learning

Kalia, D., & Singh, T. R. (2025) · International Conference on Image Information Processing (ICIIP) · doi:10.1109/iciip68302.2025.11346211 · Cited by 1 · see citing works

Architectural Constraints in LLM-Simulated Cognitive Decline: In Silico Dissociation of Memory Deficits and Generative Language as Candidate Digital Biomarkers

Pérez-Elvira, R., Oltra‐Cucarella, J., Juan, M. A., Polo-Ferrero, L., Díaz, M. Q., Bosch‐Bayard, J., Ruíz, A. S., Rashid, A. N. M. M. O., & Juárez‐Vela, R. (2026) · AI · doi:10.3390/ai7020069 · Cited by 1 · see citing works

The immune‐metabolism interactome in efferocytosis: a new paradigm for the central nervous system diseases revealed by single‐cell sequencing analysis

Zhang, H., Li, W., Xiao, P., Lu, Z., Tian, Y., & Xu, Y. (2026) · The Journal of Pathology · doi:10.1002/path.70031 · Cited by 1 · see citing works

GSK126 mitigates oxidative stress in Alzheimer disease models via an enhancer of Zeste homolog 2–H3 lysine 27 trimethylation–superoxide dismutase 1 axis

Zhong, Y., Wei, L., & Xue, R. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag008 · Cited by 1 · see citing works

PAR-1 in Alzheimer’s Disease: Pathophysiological Insights and Mechanistic Perspectives

Neha, Mandal, S., Sharma, V., Dhindsa, J., & Aran, K. R. (2026) · Current Medical Science · doi:10.1007/s11596-026-00175-y · Cited by 1 · see citing works

Artificial intelligence and machine learning based discovery of bioisosteres (BIOS) of FDA approved MAO-B inhibitors for the management of Alzheimer’s disease

Kumar, A., Jaiswal, S., Parmar, S. S., Kumar, K., Jana, S., Gawande, P., Murmu, A., Matore, B. W., Chhabra, N., Singh, J., et al. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00634-4 · Cited by 1 · see citing works

Transcranial Direct Current Stimulation Improves Cognitive Dysfunction in Amyloid Precursor Protein/Presenilin 1 Mice by Promoting Alternative Polarization of Microglia and Amyloid-Β Degradation

Xu, R., Ma, X., Wu, L., Yin, D., Zhao, L., Zhou, M., Yao, Y., Lin, R., Li, W., & Yu, K. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.03.007 · Cited by 1 · see citing works

Proteomic Study on the Amelioration of Cognitive Impairments in 3×Tg-AD Mice by Treadmill Exercise

Fu, Q., Yi, Z., Guan, Y., Tang, J., Wang, S., & Wan, C. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c01288 · Cited by 1 · see citing works

Advances in AI-based diagnosis of Alzheimer’s disease using MRI: a comprehensive survey

Raheem, H. I., López-Guede, J. M., Dara, O. A., Ramos-Hernanz, J. A., Aramendía, Í., & Teso-Fz-Betoño, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1767090 · Cited by 2 · see citing works

Mitochondrial enzyme dysfunction in Alzheimer’s disease: a systematic review of human metabolic evidence

Anar, M. A., Fathollahi, M. A., Zare, F., Farrokhi, Z., Habibzadeh, E., Hasany, S., Mirmazloumi, M., Bafrani, M. A., Kenari, F. A., Falahati, M., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01895-9 · Cited by 1 · see citing works

Unveiling the pathogenesis and therapeutic strategies of Alzheimer’s disease through cuproptosis

Xu, S., Mu, J., Wang, Z., Yang, J., Tian, D., Shi, T., Lan, J., He, P., Hao, Z., Fu, Y., et al. (2026) · BioMetals · doi:10.1007/s10534-026-00835-5 · Cited by 1 · see citing works

Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells

Morsy, N., El‐Shiekh, R. A., Ebrahium, M. M., & Srour, A. M. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110245 · Cited by 1 · see citing works

Benzothiazole-driven molecular probes and therapeutics for neurodegenerative diseases: focus on amyloid-beta (Aβ), tau, and α-synuclein

Kumar, N., khan, I., Singh, J., Kumar, K., Kumar, K., Kushwaha, V. K., Ojha, S., Dash, A. K., & Shankar, G. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00462h · Cited by 1 · see citing works

Approved Drug Regimens, Combinations, and Delivery Systems for Alzheimer’s Disease

Reddy, G. V. R., & Thalla, S. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_9 · Cited by 1 · see citing works

New Peripheral Pyridine‐Substituted Cobalt, Copper, and Manganese Phthalocyanines as Potential In Vitro Acetyl/Butyrylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease

Yalazan, H., Seyhan, G., Özkan, Ş., Barut, B., Bıyıklıoğlu, Z., & Kantekın, H. (2025) · Applied Organometallic Chemistry · doi:10.1002/aoc.70045 · Cited by 1 · see citing works

Correlations between ghrelin gene polymorphisms, cognitive function, and activities of daily living among elderly patients with Alzheimer’s disease

Liu, W., Wu, L., Hu, J., & Gao, Z. (2025) · Annals of Human Biology · doi:10.1080/03014460.2025.2507048 · Cited by 1 · see citing works

Opposing and antagonizing effects of SARS-CoV-2/COVID-19 infection and recombinant zoster vaccination on the risk of late-onset Alzheimer diseasePreprint

Rose, C., Liu, S., Bush, W. S., Haines, J. L., Williams, S. M., & Crawford, D. C. (2026) · medRxiv · doi:10.64898/2026.01.21.26344555 · Cited by 1 · see citing works

Resistencia insulínica y Enfermedad de Alzheimer. Relación de comorbilidad para el deterioro cognitivo.

Wonsey, B., Vera, C. A. M., Macías, J. N. Z., Arcentales, M. J. V., & Alencastro, J. A. P. (2025) · Revista Social Fronteriza · doi:10.59814/resofro.2025.5(1)571

A case of chronic lymphocytic leukaemia with initial symptoms of cognitive impairmentPreprint

Ye, B., Huang, Y., & Lai, W. (2025) · Research Square · doi:10.21203/rs.3.rs-5849396/v1

Key genes and pathways in asparagine metabolism in Alzheimer’s Disease: a bioinformatics approachPreprint

Lan, X., Feng, G., Li, Q., Shi, Y., Qin, S., & Zhong, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650586

The Novel Melatonin Analog Containing Donepezil Fragment Prevents Cognitive Impairments and Associated Oxidative Stress in a Hybrid Rat Model of Melatonin Deficiency and icvAβ1-42

Ivanova, P., Kortenska, L., Angelova, V. T., & Tchekalarova, J. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146553

Anti-amyloid antibody effects on Aβ-42 protein aggregates profiled using nanospectroscopyPreprint

Kummer, N., Cihova, M., & Nirmalraj, P. N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.17.665305

Comparative analysis of FDA-approved Alzheimer’s therapies: symptomatic and disease-modifying approaches

Khaled, M. A. Q. R., & Hazar‐Yavuz, A. N. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1707084

Association of triglyceride-glucose index (TyG) and a body shape index (ABSI) with cognitive decline and dementia risk

Yang, S., Cui, L., Zhang, J., Yang, Y., Huo, J., Ding, Y., Zhang, J., He, S., & Li, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354418

Design, synthesis, biological evaluation, and in silico studies of cholinesterase inhibitors based on the 2-aminothiazole scaffold

Du, W.-R., Zhou, X.-W., Wang, Y., & Ma, Z.-Y. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03468-4

Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease

Zhao, M., Yang, J., Cheng, H., Yong Fan, A., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251384967

Dual Inhibitors Targeting G9a and GSK-3β: Translational Perspectives on Alzheimer’s Disease TreatmentPreprint

Bellver-Sanchis, A., Sanchez-Arfelis, A., Choudhary, B. S., Irisarri, A., Vilella, M. R., Sukanya, S., Banerjee, D. R., Morales-García, J. A., Wüst, C., Castellanos, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684310

Basil seeds unlock memory: Hydroalcoholic extract of Ocimum basilicum reverses haloperidol-induced cognitive deficits in Mice

Palanivelu, A., Veeraraghavan, B., Mohan, D., Ashok, C., Jeyabalan, S., Wong, L. S., Sekar, M., Subramaniyan, V., Dhanasekaran, S., & Thamaraikani, T. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100719

Heterotrimetallic Au@Cu2Se nanozymes target inflamed neurons via suppression of oxidative stress and apoptosis to alleviate Alzheimer's disease

Jing, C., Li, J., Yu, D., Chao, M., Yan, H., Ge, K., Ma, G., Wang, J., Gao, F., & Zhang, G. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102646 · Cited by 1 · see citing works

Integrating machine learning and experiments to elucidate the potential molecular mechanisms of methylparaben-induced Alzheimer’s disease: evidence from a Tau hyperphosphorylation cell model

Zhang, H. E., Xiao, M. L., Ji, J., Cheng, Y., & Fang, L. (2025) · BMC Neurology · doi:10.1186/s12883-025-04582-x

Reveal the mechanism of action of donepezil combined with nimodipine in the treatment of Alzheimer's disease via metabolomics and lipidomics analyses in rats

Ji, Y., Cui, X., Ding, Z., Wang, X. Y., Wang, Y., Zhang, Y., Yuan, Z., Chang, Z., Liu, K., & Liu, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251407109

Possible Mechanisms of Ghrelin and Frailty

刘, 新. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2026.161011

GFAP and the genetic code of astrocyte activation in Alzheimer’s disease

Upadhyay, R., Srinivasan, T. B., Umapriya, R., Chandrapragasam, V., & Sevanan, M. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.007

Mitochondrial Crosstalk in Neurodegeneration: Mechanistic Pathways, Quality Control, and Therapeutic Perspectives

Sehgal, A., Kumar, P., & Singh, A. (2026) · Probecell Science · doi:10.65807/prob.sci.2025.2.2.5

Overexpression of PGRMC2 in astrocytes improved cognitive function in a mouse model of Alzheimer’s disease by modulating neuroinflammation

Zhu, T., Zhou, C., Zhou, H., Shen, F., Wang, S., Zhou, Y., Jin, G., Zu, J., Yang, X., Shi, H., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07862-3

Optimized Deep Learning Architecture for Early Alzheimer’s Detection Through MRI-based Feature Analysis

Gnanagurusamy, A., Vinod Kumar, D., Vijay Balaji, P., Shalini, C. R., R, S. A. L., & Savitha, S. (2025) · International Conference on Evolutionary Computing and Mobile Sustainable Networks (ICECMSN) · doi:10.1109/icecmsn68058.2025.11383546

Antiamyloid Antibody Effects on Aβ-42 Protein Aggregates Profiled Using Nanospectroscopy

Kummer, N., Cihova, M., & Nirmalraj, P. N. (2026) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.5c00188

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer’s glucose impairment

Upadhyay, R., Santhosh, S., Malathi, R., Kumari, P. S., Vijayanand, S., & Sevanan, M. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.010

The Science of Memory Loss: Insights into Alzheimer’s Disease

Starzyk, A., & Charzewski, P. (2025) · Quality in Sport · doi:10.12775/qs.2025.38.57948

The Alzheimer's Dieases

Siddhant Sawatkar, S. T. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.14544287

Unveiling the complexity of Alzheimer's disease: Introduction and its pathophysiology

Shabir, S., & Singh, M. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00012-4

Understanding Alzheimer's Disease: A Comprehensive Review

Reddy, G. S., Krishna, P. V., & Reddy, N. A. (2024) · International Journal of Research in Pharmacology & Pharmacotherapeutics · doi:10.61096/ijrpp.v13.iss3.2024.273-279

A Review Article on Alzheimer's disease (AD): Current Landscape in Treatment Research for Alzheimer's disease

Damarla, N., Meghasri, & Shivaraj, D. R. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.20916845